[] It may be the consequence of problems with the reproductive systems of the male, female, or both couples that impact their capacity to achieve pregnancy
Patent Search Methodology Comprehensive patent landscaping was conducted until July 13, 2024 to identify granted patents (currently active and expired) and patent applications (currently pending and abandoned) at the United States Patent and Trademark Office (USPTO) for the drug products Ozempic, Rybelsus and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide)
Important safety considerations for transdermal patches: Avoid applying external heat (such as heating pads, hot water bottles, electric blankets, or prolonged sun exposure) to the patch area, as this may increase drug absorption and side effects Do not cut patches or apply additional adhesives unless specifically instructed to do so Wash hands thoroughly after handling patches to avoid transferring medication to eyes or mucous membranes For patients currently using licensed injectable GLP-1 receptor agonists, continue to follow the administration instructions provided in the PIL and by your healthcare team
While using a medication from each class in combination does not pose a safety concern for patients, there is no evidence supporting additive efficacy with this combination
Some patients need a slower start, especially if they are sensitive to nausea, digestive changes, or appetite shifts